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Prolonged opioid use after lumbar fusion surgery is implicated with increased 
hospital readmissions, higher postoperative pain scores, and longer return to work time.  
There are several non-modifiable risk factors for postoperative opioid use including 
socioeconomic status and gender. The purpose of this study was to determine the effects of 
opioid-tolerance on PROMs and to determine risk factors for prolonged opioid use after 
lumbar spine surgery. 
 
Method: 
Using retrospective cohort analysis, patients who underwent lumbar spinal fusion at 
TJUH were identified and determined to be either opioid-naïve or opioid-tolerant using the 
Pennsylvania PDMP. Outcomes included number of opioid tablets consumed, duration of 
time using opioids, and patient-reported outcome measures (ODI, PCS-12, MCS-12, VAS 
Back, VAS Leg). Univariate and multivariate analysis were used to compare outcomes 
between the two groups. Logistic regression was used to determine independent 
predictors for prolonged opioid use which was defined as greater than one postoperative 
opioid prescription script filled. 
 
Results: 
A total of 260 patients were included in the final cohort, of which, 138 were opioid-
tolerant and 122 were opioid naïve.  Opioid-tolerant patients showed decreased 
improvement in PROMs compared to the opioid-naïve patients (p=0.043). The number of 
preoperative pills prescribed was a significant predictor for prolonged opioid use after 
lumbar fusion.  
 
Conclusion: 
The number of pills prescribed preoperatively was found to be a predictor for 
prolonged opioid use after lumbar fusion surgery. Overall, our results demonstrated that 
naïve patients have improved health-related quality of life outcome scores compared to 
opioid-tolerant patients after lumbar fusion.  
 
 
 
